|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 203.00 INR | +0.47% |
|
-4.54% | -2.47% |
| Feb. 13 | Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026 | CI |
| Feb. 06 | Viyash Scientific Limited, Q3 2026 Earnings Call, Feb 06, 2026 |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.39 | 2.58 | -0.64 | 0.95 | 4.01 | |||||
Return on Total Capital | 9.64 | 3.38 | -0.83 | 1.22 | 5.14 | |||||
Return On Equity % | 13.85 | 5.94 | -16.38 | -4.05 | 4.35 | |||||
Return on Common Equity | 13.49 | 5.81 | -17.42 | -5.29 | 3.21 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 47.38 | 42.32 | 39.61 | 42.67 | 46.02 | |||||
SG&A Margin | 13.83 | 16.52 | 18.42 | 18.6 | 18.68 | |||||
EBITDA Margin % | 15.36 | 6.99 | 2.19 | 5.61 | 10.2 | |||||
EBITA Margin % | 12.89 | 4.38 | -0.49 | 2.34 | 7.11 | |||||
EBIT Margin % | 12.39 | 4.13 | -1.08 | 1.7 | 6.49 | |||||
Income From Continuing Operations Margin % | 7.67 | 3.19 | -8.58 | -2.16 | 2.08 | |||||
Net Income Margin % | 7.01 | 2.92 | -8.53 | -2.62 | 1.41 | |||||
Net Avail. For Common Margin % | 7.01 | 2.92 | -8.53 | -2.62 | 1.41 | |||||
Normalized Net Income Margin | 6.01 | 2.08 | -2.49 | -2.05 | 0.96 | |||||
Levered Free Cash Flow Margin | 5.59 | -0.3 | -3.98 | 2.93 | 2.92 | |||||
Unlevered Free Cash Flow Margin | 6.47 | 0.3 | -2.67 | 5.05 | 5.18 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.95 | 1 | 0.95 | 0.89 | 0.99 | |||||
Fixed Assets Turnover | 3.87 | 4.2 | 4.19 | 4.13 | 5.08 | |||||
Receivables Turnover (Average Receivables) | 4.1 | 4.18 | 4.24 | 4.05 | 4.44 | |||||
Inventory Turnover (Average Inventory) | 2.96 | 2.66 | 2.47 | 2.27 | 2.29 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.55 | 1.54 | 1.5 | 1.31 | 1.73 | |||||
Quick Ratio | 0.9 | 0.76 | 0.73 | 0.65 | 0.85 | |||||
Operating Cash Flow to Current Liabilities | 0.25 | 0.06 | 0.03 | 0.05 | 0.17 | |||||
Days Sales Outstanding (Average Receivables) | 89.12 | 87.24 | 86.08 | 90.39 | 82.2 | |||||
Days Outstanding Inventory (Average Inventory) | 123.22 | 137.14 | 147.61 | 161.34 | 159.41 | |||||
Average Days Payable Outstanding | 107.84 | 98.5 | 107.08 | 117.57 | 105.75 | |||||
Cash Conversion Cycle (Average Days) | 104.5 | 125.88 | 126.61 | 134.16 | 135.87 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 35.56 | 49.28 | 59.21 | 68.4 | 62.47 | |||||
Total Debt / Total Capital | 26.23 | 33.01 | 37.19 | 40.62 | 38.45 | |||||
LT Debt/Equity | 17.92 | 22.19 | 29.33 | 24.1 | 38.97 | |||||
Long-Term Debt / Total Capital | 13.22 | 14.87 | 18.42 | 14.31 | 23.98 | |||||
Total Liabilities / Total Assets | 44.25 | 48.64 | 51.01 | 53.72 | 51.91 | |||||
EBIT / Interest Expense | 8.76 | 4.32 | -0.52 | 0.5 | 1.8 | |||||
EBITDA / Interest Expense | 11.23 | 7.85 | 1.28 | 1.79 | 2.95 | |||||
(EBITDA - Capex) / Interest Expense | 8.49 | 5.45 | -1.62 | 1.12 | 2.25 | |||||
Total Debt / EBITDA | 1.28 | 3.44 | 11.62 | 5.87 | 2.92 | |||||
Net Debt / EBITDA | 1 | 2.88 | 10.53 | 5.06 | 2.53 | |||||
Total Debt / (EBITDA - Capex) | 1.69 | 4.96 | -9.24 | 9.34 | 3.82 | |||||
Net Debt / (EBITDA - Capex) | 1.33 | 4.16 | -8.37 | 8.05 | 3.32 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 15.46 | 3.76 | 0.57 | -3.6 | 13.26 | |||||
Gross Profit, 1 Yr. Growth % | 15.9 | -7.31 | -5.88 | 3.85 | 22.14 | |||||
EBITDA, 1 Yr. Growth % | 25.96 | -52.79 | -68.31 | 146.45 | 106.07 | |||||
EBITA, 1 Yr. Growth % | 30.79 | -64.7 | -111.43 | -556.09 | 244.44 | |||||
EBIT, 1 Yr. Growth % | 34.76 | -65.38 | -126.48 | -251.66 | 332.86 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 27.31 | -56.86 | -372.49 | -75.72 | -208.94 | |||||
Net Income, 1 Yr. Growth % | 36.53 | -56.78 | -395.83 | -70.4 | -160.99 | |||||
Normalized Net Income, 1 Yr. Growth % | 76.3 | -64.02 | -221.63 | -20.92 | -153.18 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 35.09 | -57.14 | -399.39 | -70.44 | -158.92 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.59 | -4.88 | 3.56 | -1.56 | 8.2 | |||||
Inventory, 1 Yr. Growth % | 20.48 | 31.63 | -0.54 | 0.04 | 11.29 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.28 | -6.47 | 7.93 | -11.62 | -3.79 | |||||
Total Assets, 1 Yr. Growth % | -4.79 | 3.51 | 5.39 | 0.74 | 4 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.35 | -11.38 | -11.75 | -7.79 | 11.76 | |||||
Common Equity, 1 Yr. Growth % | 5.9 | -4.84 | 0.97 | -6.04 | 7.3 | |||||
Cash From Operations, 1 Yr. Growth % | -0.5 | -73.34 | -45.06 | 82.03 | 172.47 | |||||
Capital Expenditures, 1 Yr. Growth % | 29.73 | -38.55 | 165.46 | -64.25 | 26.88 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 62.49 | -105.65 | 11.03K | -171.09 | 12.88 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 31 | -95.08 | -578.53 | -282.27 | 16.09 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 14.46 | 9.46 | 2.15 | -1.54 | 4.49 | |||||
Gross Profit, 2 Yr. CAGR % | 15.86 | 3.65 | -6.6 | -1.13 | 12.62 | |||||
EBITDA, 2 Yr. CAGR % | 26.91 | -22.89 | -61.41 | -11.62 | 125.36 | |||||
EBITA, 2 Yr. CAGR % | 32.95 | -32.06 | -79.99 | -27.81 | 296.35 | |||||
EBIT, 2 Yr. CAGR % | 36.36 | -31.7 | -69.84 | -36.63 | 156.21 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 35.52 | -25.89 | 8.06 | -18.67 | -48.57 | |||||
Net Income, 2 Yr. CAGR % | 40.05 | -23.18 | 12.67 | -6.42 | -57.51 | |||||
Normalized Net Income, 2 Yr. CAGR % | 73.82 | -20.35 | -34.17 | -1.93 | -35.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 39.09 | -23.91 | 12.58 | -5.92 | -58.27 | |||||
Accounts Receivable, 2 Yr. CAGR % | 11.53 | 1.63 | -0.75 | 0.97 | 3.2 | |||||
Inventory, 2 Yr. CAGR % | 14.94 | 25.93 | 14.42 | -0.25 | 5.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 19.34 | -4.4 | 0.61 | -2.33 | -7.79 | |||||
Total Assets, 2 Yr. CAGR % | 0.17 | -0.73 | 4.79 | 3.04 | 2.35 | |||||
Tangible Book Value, 2 Yr. CAGR % | 8.78 | -0.21 | -12.44 | -9.79 | 1.52 | |||||
Common Equity, 2 Yr. CAGR % | 1.47 | 0.39 | -2 | -2.6 | 0.41 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.55 | -48.49 | -61.73 | 0 | 122.7 | |||||
Capital Expenditures, 2 Yr. CAGR % | 44.09 | -10.71 | 27.72 | -2.59 | -32.65 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 51.01 | -70.05 | -12.74 | 789.65 | -10.42 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 31.02 | -74.88 | -33.67 | 195.33 | 45.46 | |||||
Dividend Per Share, 2 Yr. CAGR % | 58.11 | - | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 17.11 | 10.78 | 6.41 | 0.2 | 3.17 | |||||
Gross Profit, 3 Yr. CAGR % | 20.24 | 7.56 | 0.37 | -3.24 | 6.08 | |||||
EBITDA, 3 Yr. CAGR % | 33.92 | -8.72 | -42.75 | -28.4 | 17.19 | |||||
EBITA, 3 Yr. CAGR % | 42.09 | -14.55 | -62.59 | -43.27 | 21.53 | |||||
EBIT, 3 Yr. CAGR % | 54.5 | -13.66 | -50.33 | -48.34 | 20.23 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 117.24 | -7.47 | 14.13 | -34.31 | -10.35 | |||||
Net Income, 3 Yr. CAGR % | -39.05 | -5.36 | 20.12 | -27.84 | -18.86 | |||||
Normalized Net Income, 3 Yr. CAGR % | 155.03 | 2.82 | -8.58 | -30.02 | -20.02 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 365.64 | -6.05 | 19.64 | -27.91 | -19.51 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.24 | 5.77 | 2.27 | -1.02 | 3.32 | |||||
Inventory, 3 Yr. CAGR % | 18.57 | 20.25 | 16.41 | 9.41 | 3.46 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 15.3 | 10.03 | -0.36 | -3.64 | -2.82 | |||||
Total Assets, 3 Yr. CAGR % | 1.22 | 1.27 | 1.49 | 3.42 | 3.35 | |||||
Tangible Book Value, 3 Yr. CAGR % | 10.19 | 1.6 | -4.85 | -10.91 | -3.11 | |||||
Common Equity, 3 Yr. CAGR % | 3.96 | -0.68 | 0.56 | -3.37 | 0.59 | |||||
Cash From Operations, 3 Yr. CAGR % | 36.38 | -35.87 | -47.38 | -35.64 | 39.67 | |||||
Capital Expenditures, 3 Yr. CAGR % | 3.96 | 8.46 | 28.39 | -16.45 | 6.38 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 28.05 | -49.88 | 6.5 | -18.51 | 347.05 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 70.03 | -56.44 | -17.35 | -7.09 | 116.34 | |||||
Dividend Per Share, 3 Yr. CAGR % | 35.72 | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.57 | 15.63 | 10.88 | 5.68 | 5.64 | |||||
Gross Profit, 5 Yr. CAGR % | 17.9 | 13.94 | 8.69 | 3.99 | 5.1 | |||||
EBITDA, 5 Yr. CAGR % | 27.68 | 11.14 | -18.59 | -9.98 | -0.96 | |||||
EBITA, 5 Yr. CAGR % | 61.58 | 14.77 | -35.13 | -20.24 | -3.83 | |||||
EBIT, 5 Yr. CAGR % | 60.33 | 26.31 | -19.63 | -23.83 | -4.26 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 42.2 | 26.58 | 64.3 | -12.24 | -17.03 | |||||
Net Income, 5 Yr. CAGR % | 38.89 | 24.44 | -22.07 | -5.92 | -20.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | 47.29 | 36 | 48.37 | 0.7 | -20.31 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 31.98 | 28.43 | 163.89 | -6.23 | -21.49 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.46 | 5.27 | 5.71 | 3.82 | 2.64 | |||||
Inventory, 5 Yr. CAGR % | 14.37 | 16.69 | 16.89 | 11.59 | 11.92 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -4.12 | -4.1 | 9.19 | 4.97 | -3.4 | |||||
Total Assets, 5 Yr. CAGR % | -1.84 | -5.42 | 2.63 | 2.11 | 1.84 | |||||
Tangible Book Value, 5 Yr. CAGR % | -7.82 | -7.36 | 0.51 | -3.5 | -2.35 | |||||
Common Equity, 5 Yr. CAGR % | -5.11 | -6.65 | 1.53 | -1.46 | 0.5 | |||||
Cash From Operations, 5 Yr. CAGR % | 362.89 | 33.59 | -17.96 | -23.4 | -6.29 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.22 | -16.24 | 12.88 | 3.9 | -0.82 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -12.12 | -34.48 | 9.32 | 3.8 | -0.62 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.68 | -25.2 | 16.2 | 6.16 | 3.62 |
- Stock Market
- Equities
- VIYASH Stock
- Financials Viyash Scientific Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















